Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Forstenpointner

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Pain Research|December 7, 2019
Neuroimaging Of Cold Allodynia Reveals A Central Disinhibition Mechanism Of PainJulia Forstenpointner, Andreas Binder, Rainer Maag, et al.
European Journal of Pain (London, England)|January 9, 2026
Response to High-Dose Topical Capsaicin in Neuropathic Pain: Absence of Deep Pain as a Predictor of Analgesic EffectManon Sendel, Lena Ehmke, Andreas Dunst, et al.
Medicine|December 23, 2022
The pandemic's effect on a patient cohort with painful polyneuropathy in 2020: A longitudinal study on pain, mood, and everyday lifeDilara Kersebaum, Manon Sendel, Sophie-Charlotte Fabig, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|May 30, 2024
Cold-evoked potentials in Fabry disease and polyneuropathyDilara Kersebaum, Manon Sendel, Josephine Lassen, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|March 15, 2024
Beyond numbers: integrating qualitative analysis into quantitative sensory testing for neuropathic painMartine Bordeleau, Matthieu Vincenot, Miroslav Bačkonja, et al.
Pain|September 2, 2020
No pain, still gain (of function): the relation between sensory profiles and the presence or absence of self-reported pain in a large multicenter cohort of patients with neuropathyJulia Forstenpointner, Ruth Ruscheweyh, Nadine Attal, et al.
European Journal of Pain (London, England)|November 10, 2020
The serotonin receptor 2A (HTR2A) rs6313 variant is associated with higher ongoing pain and signs of central sensitization in neuropathic pain patientsJuliane Sachau, Henrike Bruckmueller, Janne Gierthmühlen, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Pain Research|December 7, 2019
Neuroimaging Of Cold Allodynia Reveals A Central Disinhibition Mechanism Of PainJulia Forstenpointner, Andreas Binder, Rainer Maag, et al.
European Journal of Pain (London, England)|January 9, 2026
Response to High-Dose Topical Capsaicin in Neuropathic Pain: Absence of Deep Pain as a Predictor of Analgesic EffectManon Sendel, Lena Ehmke, Andreas Dunst, et al.
Medicine|December 23, 2022
The pandemic's effect on a patient cohort with painful polyneuropathy in 2020: A longitudinal study on pain, mood, and everyday lifeDilara Kersebaum, Manon Sendel, Sophie-Charlotte Fabig, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|May 30, 2024
Cold-evoked potentials in Fabry disease and polyneuropathyDilara Kersebaum, Manon Sendel, Josephine Lassen, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|March 15, 2024
Beyond numbers: integrating qualitative analysis into quantitative sensory testing for neuropathic painMartine Bordeleau, Matthieu Vincenot, Miroslav Bačkonja, et al.
Pain|September 2, 2020
No pain, still gain (of function): the relation between sensory profiles and the presence or absence of self-reported pain in a large multicenter cohort of patients with neuropathyJulia Forstenpointner, Ruth Ruscheweyh, Nadine Attal, et al.
European Journal of Pain (London, England)|November 10, 2020
The serotonin receptor 2A (HTR2A) rs6313 variant is associated with higher ongoing pain and signs of central sensitization in neuropathic pain patientsJuliane Sachau, Henrike Bruckmueller, Janne Gierthmühlen, et al.
Pageof 4